Rigshospitalet
Copenhagen, 2100, Denmark
NCT Number: NCT01574859
Retrospective trial of 300 patients with pituitary insufficiency treated in Department of Medica Endocrinology, Rigshospitalet, Copenhagen University concerning levothyroxine (T4) replacement and cardiovascular risk factors. The hypothesis is that subtle central hypothyroidism is associated with adverse cardiac risk factors, such as body composition and serum lipids, and that improved T4 replacement will eliminate this increased risk, independently of other pituitary hormone replacements.
Looking for future studies?
Notify MeAll sexes
Observational
Copenhagen, 2100, Denmark
Retrospective trial of 300 patients with pituitary insufficiency treated in Department of Medical Endocrinology, Rigshospitalet, Copenhagen University concerning levothyroxine (T4) replacement and cardiovascular risk profile. The patient files are recruited among hypopituitary patients treated with growth hormone from the period 1993 to 2008. The trial is a retrospective assessment of data already collected for routine purposes and thus an audit of daily clinical practice. All information on the patients is obtained from the paper and electronic files existing in the department and no new measurements are foreseen.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
titration of T4 according to biochemical values
Time frame: March 2002 - March 2013
Rigshospitalet, Denmark
Other
Central Hypothyroidism and Cardiovascular Risk Factors
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00360074
Brain Diseases, Central Nervous System Diseases
Freiburg im Breisgau, Baden-Wurttemberg, Germany
View Trial DetailsNCT04897802
Behavior, Brain Diseases
Barcelona, Spain
View Trial DetailsNCT07015645
Brain Diseases, Brain Neoplasms
Damietta, Egypt
View Trial DetailsNCT05319301
Behavior, Brain Diseases
Barcelona, Spain
View Trial Details